Literature DB >> 7165315

Epidermal Langerhans cell number and morphology during oral retinoid treatment.

L Koulu, C T Jansén.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7165315     DOI： 10.1007/bf00510403

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN： 0340-3696            Impact factor:   3.017


× No keyword cloud information.
  10 in total

1.  A model implicating the Langerhans cell in keratinocyte proliferation control.

Authors:  C S Potten; T D Allen
Journal:  Differentiation       Date:  1976-01-13       Impact factor: 3.880

2.  Systemic treatment of psoriasis with a new aromatic retinoid. Preliminary evaluation of a multicenter controlled study in the Federal Republic of Germany.

Authors:  G Goerz; C E Orfanos
Journal:  Dermatologica       Date:  1978

3.  Suction blister device for separation of viable epidermis from dermis.

Authors:  U Kiistala
Journal:  J Invest Dermatol       Date:  1968-02       Impact factor: 8.551

4.  Giant Langerhans cells induced by psoralen and ultraviolet radiation.

Authors:  L Juhlin; W B Shelley
Journal:  Arch Dermatol Res       Date:  1979-11       Impact factor: 3.017

Review 5.  Retinoids, cancer, and the skin.

Authors:  P M Elias; M L Williams
Journal:  Arch Dermatol       Date:  1981-03

6.  New staining techniques for the Langerhans cell.

Authors:  L Juhlin; W B Shelley
Journal:  Acta Derm Venereol       Date:  1977       Impact factor: 4.437

7.  Cell-mediated immunity in Darier's disease: effect of systemic retinoid therapy.

Authors:  A M Soppi; E Soppi; J Eskola; C T Jansén
Journal:  Br J Dermatol       Date:  1982-02       Impact factor: 9.302

8.  Disappearance of epidermal Langerhans cells during PUVA therapy.

Authors:  P S Friedmann
Journal:  Br J Dermatol       Date:  1981-08       Impact factor: 9.302

9.  Differential in vitro effects of etretinate and retinoic acid on the PHA and con A induced lymphocyte transformation, suppressor cell induction and leukocyte migration inhibitory factor (LMIF) production.

Authors:  E Soppi; R Tertti; A M Soppi; A Toivanen; C T Jansén
Journal:  Int J Immunopharmacol       Date:  1982

10.  Ultraviolet light depletes surface markers of Langerhans cells.

Authors:  W Aberer; G Schuler; G Stingl; H Hönigsmann; K Wolff
Journal:  J Invest Dermatol       Date:  1981-03       Impact factor: 8.551
  10 in total
  5 in total

Review 1.  Role of epidermal Langerhans cells in viral infections.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

Review 2.  Does neoplasia in-situ develop due to the interaction of Epstein-Barr virus or herpes simplex virus-2 with Langerhans cells in the epithelium?

Authors:  Y Becker
Journal:  Virus Genes       Date:  1988-07       Impact factor: 2.332

3.  Epidermal Langerhans cells in erythrokeratodermia variabilis. Histochemical and ultrastructural investigations before and after treatment with etretinate (RO 10-9359).

Authors:  J G van der Schroeff; D J Ruiter; G T Bots
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

4.  Effect of etretinate on the distribution of Langerhans cells and T. lymphocytes in psoriatic skin.

Authors:  A Ranki; J Lauharanta; L Kanerva
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

5.  Effects of aromatic retinoid (Ro 109359) on Langerhans' cells in lichen planus.

Authors:  R A Fernandez-Bussy; D Schmitt; G Mauduit; J Thivolet
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.